US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making | Business
PHILADELPHIA--(BUSINESS WIRE)--Jun 21, 2023--
Source: valdostadailytimes.com